GlassScriptPhysician profile
Michael Stephen Adams
NPI 1407098890
$5,775.56
in general payments reported to CMS, 2019-2025
14 companies · $1,101 in 2025
The $1,101 reported for 2025 was more than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $44.78 · 2021: $334 · 2022: $3,101 · 2023: $138 · 2024: $1,056 · 2025: $1,101.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,552 · Food and Beverage: $743.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,552.12 |
| Food and Beverage | $743.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $3,866.25 | 2022-2025 | Intellis Adaptivestim, Kyphon Express II Kyphopak Tray, Tourguide Steerable Sheath |
| Stryker Corporation | $949.20 | 2024 | Spinejack, Optablate |
| Boston Scientific Corporation | $219.38 | 2022-2025 | Wavewriter Alpha Prime 16, Intracept |
| Horizon Therapeutics Plc | $137.70 | 2020-2022 | |
| Collegium Pharmaceutical, INC. | $130.32 | 2021-2022 | |
| Abbvie INC. | $124.95 | 2023 | Vraylar |
| Biodelivery Sciences International, INC. | $123.25 | 2021 | |
| Abbott Laboratories | $106.55 | 2024 | Eterna |
| Allergan, INC. | $41.84 | 2020-2022 | |
| Pfizer INC. | $25.30 | 2021 | |
| Stimwave Technologies Incorporated | $15.42 | 2020 | |
| Arbor Pharmaceuticals, INC. | $15.41 | 2021 | |
| Bioventus LLC | $12.19 | 2021 | |
| Vgi Medical, LLC | $7.80 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Adams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.